Dr. Chiuzan's statistical research area focuses on development of early phase clinical trial designs (particular interest in cancer targeted and immunotherapeutic agents) and leveraging real-world evidence to improve trial outcomes. She currently serves as one of the main statisticians for the Herbert Irving Comprehensive Cancer Center and as faculty consultant for the Biostatistics Fee-For-Service Consulting Program.